文献速递眼底病与葡萄膜炎

积雪草酸抑制高糖诱导视网膜微血管内皮细胞血管生成及Slit-Robo信号

[Effects of asiatic acid on angiogenesis and Slit-Robo signaling in retinal microvascular endothelial cells induced by high glucose].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2026-01-01

该实验研究探讨积雪草酸(AA)对高糖诱导的人视网膜微血管内皮细胞(hRMEC)血管生成的影响及机制。10 μmol/L AA不影响正常hRMEC活力,但显著抑制高糖下的细胞活力、迁移和小管形成,并降低Slit2、Robo1及p-PI3K p85、p-AKT表达;PI3K激活剂740Y-P可逆转AA效应。结论提示AA可能部分通过抑制PI3K通路抑制Slit-Robo信号活化及血管生成。

要点

  • 10 μmol/L AA不影响正常hRMEC活力(0.803±0.05,P=0.662),但抑制高糖下细胞活力(1.049±0.12,P<0.001)。
  • AA降低高糖诱导的hRMEC迁移率、小管形成数、主连接点数及总管长度。
  • AA下调Slit2、Robo1及p-PI3K p85、p-AKT表达,740Y-P可逆转其效应。

核心结论

  • 积雪草酸可能部分通过抑制PI3K通路,抑制高糖诱导的hRMEC中Slit-Robo信号活化及细胞活力、迁移和血管生成。

研究设计与样本

  • 实验研究,采用MTT法筛选积雪草酸非细胞毒性浓度,构建高糖诱导hRMEC损伤模型。
  • 模型分为对照组、高糖组、甘露醇组、高糖+积雪草酸组、高糖+积雪草酸+740Y-P组、高糖+LY294002组、高糖+二甲基亚砜组。
  • 检测指标包括细胞活力、迁移能力、小管形成能力及Slit2、Robo1、PI3K p85、p-PI3K p85、AKT、p-AKT的mRNA和蛋白表达。

主要发现

  • 与对照组比较,高糖组细胞活力(1.609±0.14)、迁移率(70.90%±5.39%)、小管形成数(61.89±2.17)、主连接点数(96.22±3.86)、总管长度[(28 043.78±1 472.75)μm]均显著升高(均P<0.001)。
  • 高糖组Slit2 mRNA(4.07±0.31)、Slit2蛋白(4.76±0.72)、Slit2分泌量[(5.889±0.746)ng/ml]、Robo1 mRNA(4.46±0.17)、Robo1蛋白(6.00±0.35)、p-PI3K p85(6.61±0.46)及p-AKT(6.02±0.68)均较对照组显著升高(均P<0.001)。
  • 与高糖+DMSO组比较,高糖+积雪草酸组细胞活力(1.052±0.14,P=0.002)、迁移率(30.70%±3.97%)、小管形成数(42.22±4.17,P=0.004)、主连接点数(69.89±1.34,P<0.001)、总管长度[(19 853.11±1 141.85)μm,P<0.001]均显著降低。
  • 高糖+积雪草酸组Slit2 mRNA(2.02±0.04)、Slit2蛋白(2.12±0.17)、Slit2分泌量[(2.991±0.479)ng/ml]、Robo1 mRNA(1.99±0.13)、Robo1蛋白(2.86±0.28)、p-PI3K p85(1.84±0.22)及p-AKT(2.30±0.15)均较高糖+DMSO组显著降低(均P<0.001)。
  • 与高糖+积雪草酸组比较,高糖+积雪草酸+740Y-P组细胞活力(1.517±0.14,P=0.012)、迁移率(68.12%±3.70%)、小管形成数(56.44±4.07,P=0.009)、主连接点数(93.67±3.85)、总管长度[(27 751.22±1 148.29)μm]均显著升高(均P<0.001);Slit2 mRNA(3.47±0.15)、Slit2蛋白(4.05±0.25)、Slit2分泌量[(4.763±0.565)ng/ml,P=0.023]、Robo1 mRNA(3.95±0.11)、Robo1蛋白(5.39±0.46)、p-PI3K p85(9.66±1.79)及p-AKT(10.42±1.93)均显著升高(均P<0.001)。

关键数值与推荐

  • 10 μmol/L积雪草酸处理正常hRMEC的细胞活力为0.803±0.05,与对照相比P=0.662。
  • 高糖条件下积雪草酸处理细胞活力为1.049±0.12,与高糖+DMSO组相比P<0.001。
  • 各组间PI3K及AKT总蛋白水平差异无统计学意义(P>0.05)。

临床怎么用

  • 积雪草酸在高糖环境下抑制hRMEC增殖、迁移和血管生成,提示其可能作为糖尿病视网膜病变治疗的先导化合物。
  • 积雪草酸的作用至少部分通过抑制PI3K通路下调Slit-Robo信号活化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the effects and mechanism of asiatic acid (AA) on high glucose (HG)-induced angiogenesis of human retinal microvascular endothelial cells (hRMECs). Methods: In this experimental study, the MTT assay was used to screen the optimal concentration of AA. The HG-induced hRMEC injury models were established and divided into the control group, HG group, Mannitol group, HG+AA group, HG+AA+740Y-P group, HG+LY294002 group and HG+dimethyl sulfoxide group. Cell viability, migration and tube formation were detected by the MTT assay, scratch test and Matrigel assay, respectively. Real-time PCR and ELISA were used to detect the relative mRNA expression of Slit guidance ligand 2 (Slit2) and roundabout guidance receptor 1 (Robo1), as well as Slit2 secretion. Western blot was used to detect the protein expression of phosphatidylinositol 3-kinase p85 subunit (PI3K p85), phosphorylated PI3K p85 (p-PI3K p85), protein kinase B (AKT), phosphorylated AKT (p-AKT), Slit2 and Robo1. Results: The treatment with 10 μmol/L AA did not affect the viability of normal hRMECs (0.803±0.05) (P=0.662), but significantly inhibited cell viability under HG conditions (1.049±0.12) (P<0.001). Compared with the control group, the HG group showed significant increases in cell viability (1.609±0.14), migration rate (70.90%±5.39%), tube number (61.89±2.17), number of master junctions (96.22±3.86), total tube length [(28 043.78±1 472.75) μm], mRNA and protein expression of Slit2 (4.07±0.31 and 4.76±0.72), Slit2 secretion [(5.889±0.746) ng/ml], mRNA and protein expression of Robo1 (4.46±0.17 and 6.00±0.35), as well as protein expression of p-PI3K p85 (6.61±0.46) and p-AKT (6.02±0.68) (all P<0.001). Compared with the HG+dimethyl sulfoxide group, the HG+AA group exhibited significant decreases in cell viability (1.052±0.14) (P=0.002), migration rate (30.70%±3.97%), tube number (42.22±4.17) (P=0.004), number of master junctions (69.89±1.34) (P<0.001), total tube length [(19 853.11±1 141.85) μm] (P<0.001), mRNA and protein expression of Slit2 (2.02±0.04 and 2.12±0.17), Slit2 secretion [(2.991±0.479) ng/ml] (P<0.001), mRNA and protein expression of Robo1 (1.99±0.13 and 2.86±0.28) (P<0.001), and protein expression of p-PI3K p85 (1.84±0.22) and p-AKT (2.30±0.15) (P<0.001). Compared with the HG+AA group, the HG+AA+740Y-P group showed significant increases in cell viability (1.517±0.14) (P=0.012), migration rate (68.12%±3.70%) (P<0.001), tube number (56.44±4.07) (P=0.009), number of master junctions (93.67±3.85) (P<0.001), total tube length [(27 751.22±1 148.29) μm] (P<0.001), mRNA and protein expression of Slit2 (3.47±0.15 and 4.05±0.25) (P<0.001), Slit2 secretion [(4.763±0.565) ng/ml] (P=0.023), mRNA and protein expression of Robo1 (3.95±0.11 and 5.39±0.46) (P<0.001), and protein expression of p-PI3K p85 (9.66±1.79) and p-AKT (10.42±1.93) (P<0.001). No significant differences were observed among groups in total PI3K and AKT protein levels (P>0.05). Conclusions: AA suppresses the HG-induced Slit-Robo signaling activation, proliferation, migration and angiogenesis in hRMECs, at least in part by inhibiting the PI3K pathway, suggesting its potential as a lead compound for diabetic retinopathy therapy. 目的: 探讨积雪草酸对高糖诱导的人视网膜微血管内皮细胞(hRMEC)血管形成的影响及作用机制。 方法: 实验研究。首先采用噻唑蓝(MTT)法筛选积雪草酸作用细胞的非细胞毒性浓度。随后构建高糖诱导hRMEC损伤模型,分为对照组、高糖组、甘露醇组、高糖+积雪草酸组、高糖+积雪草酸+740Y-P组、高糖+LY294002组、高糖+二甲基亚砜(DMSO)组。分别采用MTT法、划痕实验、基底膜基质胶实验检测细胞活力、迁移能力及小管形成能力;实时荧光定量聚合酶链反应及酶联免疫吸附实验检测Slit引导配体2(Slit2)及回旋导向受体1(Robo1)的mRNA相对表达量及Slit2分泌水平;蛋白质印迹法检测磷脂酰肌醇3-激酶p85亚基(PI3K p85)、磷酸化PI3K p85(p-PI3K p85)、蛋白激酶B(AKT)、磷酸化AKT(p-AKT)、Slit2及Robo1的蛋白表达水平。 结果: 10 μmol/L的积雪草酸既不影响正常hRMEC的细胞活力(0.803±0.05)(P=0.662),又可显著抑制高糖处理下的细胞活力(1.049±0.12)(P<0.001)。与对照组比较,高糖组细胞活力(1.609±0.14)、迁移率70.90%±5.39%、小管形成数(61.89±2.17)个、主连接点数(96.22±3.86)个、总管长度(28 043.78±1 472.75)μm、Slit2 mRNA(4.07±0.31)及蛋白(4.76±0.72)表达量与分泌量(5.889±0.746)ng/ml、Robo1 mRNA(4.46±0.17)及蛋白(6.00±0.35)表达量、p-PI3K p85(6.61±0.46)及p-AKT蛋白(6.02±0.68)表达量均显著升高(均P<0.001)。与高糖+DMSO组比较,高糖+积雪草酸组细胞活力(1.052±0.14)(P=0.002)、迁移率30.70%±3.97%(P<0.001)、小管形成数(42.22±4.17)个(P=0.004)、主连接点数(69.89±1.34)个(P<0.001)、总管长度(19 853.11±1 141.85)μm(P<0.001)、Slit2 mRNA(2.02±0.04)及蛋白(2.12±0.17)表达量与分泌量(2.991±0.479)ng/ml(P<0.001)、Robo1 mRNA(1.99±0.13)及蛋白(2.86±0.28)表达量(P<0.001)、p-PI3K p85(1.84±0.22)及p-AKT蛋白(2.30±0.15)表达量(P<0.001)均显著降低。与高糖+积雪草酸组比较,高糖+积雪草酸+740Y-P组细胞活力(1.517±0.14)(P=0.012)、迁移率68.12%±3.70%(P<0.001)、小管形成数(56.44±4.07)个(P=0.009)、主连接点数(93.67±3.85)个(P<0.001)、总管长度(27 751.22±1 148.29)μm(P<0.001)、Slit2 mRNA(3.47±0.15)及蛋白(4.05±0.25)表达量(P<0.001)与分泌量(4.763±0.565)ng/ml(P=0.023)、Robo1 mRNA(3.95±0.11)及蛋白(5.39±0.46)表达量(P<0.001)、p-PI3K p85(9.66±1.79)及p-AKT蛋白(10.42±1.93)表达量(P<0.001)均显著升高。各组间PI3K及AKT总蛋白水平差异无统计学意义(P>0.05)。 结论: 积雪草酸可能部分通过抑制PI3K通路,抑制高糖诱导的hRMEC中Slit-Robo信号活化及细胞活力、迁移和血管生成,为糖尿病视网膜病变的治疗提供新的先导化合物。.

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Fang MY, Zhang FQ, Qi Y, et al. [Effects of asiatic acid on angiogenesis and Slit-Robo signaling in retinal microvascular endothelial cells induced by high glucose]. Zhonghua Yan Ke Za Zhi. 2026. PMID: 42855782. doi:10.3760/cma.j.cn112142-20260316-00105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。